Impairment Risk for Advance Payments for Exclusive Distribution Rights
First written in FY2020. 2 of 6 entries say "Restated". Latest entry: FY2025-H1.
No other company in this theme has enough history to compare yet.
- FY2025-H1MaterialisedAnnual report
「During the interim consolidated accounting period, the carrying amount of distribution rights was reduced to the recoverable amount because, owing to lower profitability, recovery of the carrying amount could no longer be expected according to the originally anticipated schedule. The decrease was recorded as an impairment loss under extraordinary losses.」
For advances relating to exclusive distribution rights and other distribution rights, recovery was no longer expected because of lower profitability, and ¥394 million relating to distribution rights was recorded as an impairment loss. The previously identified possibility of impairment has materialised as an actual loss. - FY2023-Q3RestatedAnnual report
「Long-term advances 1,574 2,817」
Long-term advances increased from ¥1,574 million at the end of the previous consolidated fiscal year to ¥2,817 million, and the balance subject to the impairment risk disclosed in the previous quarter continues to be reported. - FY2023-Q2WorsenedAnnual report
「Long-term advances 1,574 2,817」
Long-term advances increased from ¥1,574 million at the end of the previous consolidated fiscal year to ¥2,817 million, increasing the balance potentially subject to impairment risk associated with advances for exclusive distribution rights and other items. - FY2022RestatedAnnual report
「When recording long-term advances, the company obtains an appropriate valuation from external specialists as necessary and conducts an appropriate valuation each fiscal year after recognition. It has also designated the Business Development Department as the department responsible for the business, established opportunities for discussion based on regular reports, and evaluates and verifies development progress and sales plans.」
Continues external specialist valuations, annual valuations, and verification of development progress and sales plans in response to impairment risk relating to exclusive distribution rights and advances. - FY2021MitigatedAnnual report
「When recording long-term advances, the company obtains an appropriate valuation from external specialists as necessary and conducts an appropriate valuation each fiscal year after recognition. It has also designated the Business Development Department as the department responsible for the business, established opportunities for discussion based on regular reports, and evaluates and verifies development progress and sales plans.」
For the impairment risk relating to advances for exclusive distribution rights, identifies valuations by external specialists, annual valuations, and verification of development progress and sales plans by the Business Development Department as countermeasures. - FY2020First statedAnnual report
「The company records advances for exclusive distribution rights under contracts as long-term advances. As with goodwill, it is required to periodically assess whether there are indications of impairment. If impairment is determined to have occurred, the resulting impairment loss could affect the operating results and financial position of the company group.」
Newly identifies the risk of impairment losses and impacts on operating results associated with recording advances for exclusive distribution rights as long-term advances.